ASX-listed CSL, a global biotechnology company, has entered into an agreement with Netherlands-based biotech company, VarmX, to develop a new treatment to restore blood coagulation in patients taking a FXa…
The Netherlands: CSL partners with VarmX on first-in class coagulation treatment
…
…






